Colorado Founder of Stevens Johnson Syndrome Foundation Will Join 7-Year-Old SJS Victim at Washington, D.C., Press Conference

Business Wire, Feb 14, 2005

--  They Seek the FDA's Help in Reinstating a Warning Label on
    Children's Motrin About SJS

--  Jean McCawley of the SJS Foundation Will Discuss Dramatic Rise in
    Reported SJS Cases in Children

WHAT:

At 11:00 AM on Thursday, February 17th, Sabrina Brierton Johnson, a
7-year-old victim of Stevens Johnson Syndrome (SJS), and Mrs. Jean
McCawley, founder of the Stevens Johnson Syndrome Foundation, will
hold a joint press conference in the Lobby of the Hilton Washington
North, 620 Perry Parkway, Gaithersburg, MD. They seek the FDA's help
in reinstating a warning label on Children's Motrin about SJS. Mrs.
McCawley will discuss the dramatic rise in reported SJS cases in
children.

The press conference is being held relative to the FDA's three-day
meeting of the Arthritis Advisory Committee and the Drug Safety and
Risk Management Advisory Committee from February 16-18, 2005, which
will discuss the overall benefit to risk considerations for COX-2
selective NSAIDS (non-steroidal anti-inflammatory drugs) and related
agents. Sabrina's parents, Ken and Joan Brierton Johnson, and brother
Travis Johnson will attend, as well as her attorney Browne Greene.

After the press conference, Sabrina Brierton Johnson will be the first
person to speak at the FDA's Open Public Hearing segment of this
meeting at approximately 1:00 PM in the Ballrooms at the Hilton
Washington DC North. She will ask the FDA to reinstate a warning label
about SJS that was removed in 1995 when Children's Motrin was approved
for over-the-counter sale by the FDA. On behalf of the SJS Foundation,
Mrs. McCawley, through a written statement submitted to the FDA for
this Meeting, will advocate that over-the-counter ibuprofen require a
black box warning.

WHO:

Mrs. Jean McCawley, from Westminster, Colo., has an 11-year-old
daughter, Julie, who became an SJS victim when she was only 11 months
old and who is now blind as a result. Mrs. McCawley founded the SJS
Foundation in 1996 to make information about SJS more accessible to
the public. She will discuss the dramatic rise in reported SJS cases
in children, and the need to institute a Federal system to report and
track SJS cases.

Sabrina Brierton Johnson, from Topanga, Calif., filed a complaint for
damages on December 28, 2004 against Johnson & Johnson (NSYE:JNJ) in
Los Angeles Superior Court/Compton Division claiming that an allergic
reaction to taking Children's Motrin (Stevens Johnson Syndrome) caused
her to become blind and photosensitive. She claims that Defendants'
failure to warn the public or educate the medical community about the
possible risk of SJS associated with using over-the-counter Children's
Motrin makes it an unsafe product and dangerous to sell to consumers,
which is why she wants the FDA to reinstate a warning label. Sabrina
Brierton Johnson vs. Johnson & Johnson, et. al., Case Number TC
018540.

WHEN: Thursday, February 17, 2005

TIME:

11:00 AM: Sabrina Brierton Johnson and Mrs. Jean McCawley will hold a
joint press conference in the Lobby of the Hilton Washington DC North.

1:00 PM: Sabrina Brierton Johnson will address the FDA public meeting
on NSAIDS (www.fda.gov) at the Ballrooms at the Hilton Washington DC
North. See http://www.fda.gov NOTE: Time is approximate.

WHERE:

Hilton Washington DC North - Lobby
620 Perry Parkway
Gaithersburg, MD.